Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies

被引：0
|
作者：
Linda Harris
Tom O’Connell
Jonathan J. Woolley
Gilbert L’Italien
Tamela Martin
Vladimir Coric
James A. Moren
机构：
[1] Biohaven Pharmaceuticals,
[2] Medicus Economics,undefined
[3] American Headache Society,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Breakthrough; Cost; Dihydroergotamine; Intranasal; Medicaid; Migraine, acute; Migraine, prevention; Monoclonal antibody; Monthly migraine day; Triptan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1141 / 1152
页数：11
相关论文
共 50 条
  • [1] Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies
    Harris, Linda
    O'Connell, Tom
    Woolley, Jonathan J.
    L'Italien, Gilbert
    Martin, Tamela
    Coric, Vladimir
    Moren, James A.
    ADVANCES IN THERAPY, 2023, 40 (03) : 1141 - 1152
  • [2] Preventive and acute treatment for migraine patients by age and income
    Li, Zhicheng
    Lipton, Richard
    Bigal, Marcelo
    NEUROLOGY, 2007, 68 (12) : A367 - A368
  • [3] Acute and preventive treatment of menstrual migraine: a meta-analysis
    Khoo, Cindy Ciat-Wuah
    Liu, Chan-Cheng
    Lu, Michael
    Huang, Yu-Chen
    Weng, Hsing-Yu
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [4] Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans
    Slof, J
    Badia, X
    Láinez, JM
    Galván, J
    Heras, J
    NEUROLOGIA, 2005, 20 (06): : 290 - 298
  • [5] Interim Analysis on the Effectiveness of Fremanezumab for the Preventive Treatment of Migraine: The Observational PEARL Study
    Ashina, M.
    Mitsikostas, D.
    Amin, F. M.
    Kokturk, P.
    Sahin, G.
    Schankin, C.
    Dorman, P.
    Pozo-Rosich, P.
    Lyras, L.
    Myers, C.
    Ahn, A.
    Tassorelli, C.
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
  • [6] Acute and preventive treatment patterns and associated work productivity and activity impairment among patients with migraine in Germany
    Andrews, J. Scott
    Ford, Janet
    Dell'Agnello, Grazia
    Cotton, Sarah
    Tockhorn-Heidenreich, Antje
    Lombard, Louise
    Phillips, Zoe
    Jackson, James
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] OPIOID USE AMONG MIGRAINE PATIENTS TREATED WITH ACUTE AND PREVENTIVE TREATMENT
    Trenz, H.
    Khan, S.
    Singh, K. P.
    Allenback, G.
    McPheeters, J. T.
    Batra, K.
    VALUE IN HEALTH, 2023, 26 (06) : S239 - S239
  • [8] Serum CGRP in migraine patients using erenumab as preventive treatment
    Simone de Vries Lentsch
    Ingrid M. Garrelds
    A. H. Jan Danser
    Gisela M. Terwindt
    Antoinette MaassenVanDenBrink
    The Journal of Headache and Pain, 2022, 23
  • [9] Serum CGRP in migraine patients using erenumab as preventive treatment
    Lentsch, Simone de Vries
    Garrelds, Ingrid M.
    Danser, A. H. Jan
    Terwindt, Gisela M.
    MaassenVanDenBrink, Antoinette
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [10] Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
    Pablo Irimia
    David García-Azorín
    Mercedes Núñez
    Sílvia Díaz-Cerezo
    Pepa García de Polavieja
    Tommaso Panni
    Aram Sicras-Navarro
    Antoni Sicras-Mainar
    Antonio Ciudad
    The Journal of Headache and Pain, 2022, 23
12345